NFE2L2 and pancreatic neoplasm: Results from previous studies have indicated that apoptosis observed in targeting the NRF2 pathway is a consequence of ROS production [37]; however, NSLC01 induced limited ROS in both sensitive and resistant pancreatic cancer cell lines (Fig. 2E).